Shanghai INT Medical Instruments Co Stock

Shanghai INT Medical Instruments Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Shanghai INT Medical Instruments Co (1501.HK) as of Jul 26, 2026 is 18.16. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 26.38 — a change of -31.15% (lower).

EV/EBIT

18.16

YoY

-31.15%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Shanghai INT Medical Instruments Co is 2026 18.16 . EV/EBIT (Enterprise Value to EBIT) of Shanghai INT Medical Instruments Co was 2025 26.38 . It decreases by -31.15% lower compared to the previous year.

The Shanghai INT Medical Instruments Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
36.41 base
Jan 1, 2020
49.49 base
Jan 1, 2021
19.47 base
Jan 1, 2022
26.74 base
Jan 1, 2023
25.11 base
Jan 1, 2024
22.22 base
Jan 1, 2025
14.90 base
Jan 1, 2026 (e)
17.50 base
YEARPRICE-TO-EBIT
2026 est 17.50
2025 14.90
2024 22.22
2023 25.11
2022 26.74
2021 19.47
2020 49.49
2019 36.41
2018 -
2017 -
2016 -
Access this data via the Eulerpool API
Get Free API Key

Shanghai INT Medical Instruments Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Shanghai INT Medical Instruments Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Shanghai INT Medical Instruments Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Shanghai INT Medical Instruments Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Shanghai INT Medical Instruments Co grows earnings faster than its peers.

Shanghai INT Medical Instruments Co Stock analysis

What does Shanghai INT Medical Instruments Co do? Shanghai INT Medical Instruments Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai INT Medical Instruments Co stock

EV/EBIT (Enterprise Value to EBIT) of Shanghai INT Medical Instruments Co is 18.16 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Shanghai INT Medical Instruments Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Shanghai INT Medical Instruments Co